HEADER OXIDOREDUCTASE 02-JUN-09 3HOK
TITLE X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 WITH (2R, 4S)-2-[2-
TITLE 2 (4-CHLOROPHENYL)ETHYL]-2-[(1H-IMIDAZOL-1-YL)METHYL]-4[((5-
TITLE 3 TRIFLUOROMETHYLPYRIDIN-2-YL)THIO)METHYL]-1,3-DIOXOLANE: A NOVEL,
TITLE 4 INDUCIBLE BINDING MODE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HEME OXYGENASE 1;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: RESIDUES 1-233;
COMPND 5 SYNONYM: HO-1;
COMPND 6 EC: 1.14.99.3;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: HMOX1, HO, HO1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5-ALPHA;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: DELTA 233-HHO-1
KEYWDS PROTEIN-INHIBITOR COMPLEX, ALPHA HELICES, ENDOPLASMIC RETICULUM,
KEYWDS 2 HEME, IRON, METAL-BINDING, MICROSOME, OXIDOREDUCTASE,
KEYWDS 3 PHOSPHOPROTEIN, POLYMORPHISM
EXPDTA X-RAY DIFFRACTION
AUTHOR M.N.RAHMAN,Z.JIA
REVDAT 3 06-SEP-23 3HOK 1 REMARK
REVDAT 2 13-OCT-09 3HOK 1 JRNL
REVDAT 1 28-JUL-09 3HOK 0
JRNL AUTH M.N.RAHMAN,J.Z.VLAHAKIS,D.VUKOMANOVIC,W.A.SZAREK,K.NAKATSU,
JRNL AUTH 2 Z.JIA
JRNL TITL X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 WITH
JRNL TITL 2 (2R,4S)-2-[2-(4-CHLOROPHENYL)ETHYL]-2-[(1H-IMIDAZOL-1-YL)
JRNL TITL 3 METHYL]-4[((5-TRIFLUOROMETHYLPYRIDIN-2-YL)THIO)METHYL]-1,
JRNL TITL 4 3-DIOXOLANE: A NOVEL, INDUCIBLE BINDING MODE.
JRNL REF J.MED.CHEM. V. 52 4946 2009
JRNL REFN ISSN 0022-2623
JRNL PMID 19601578
JRNL DOI 10.1021/JM900434F
REMARK 2
REMARK 2 RESOLUTION. 2.19 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.4.0069
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.42
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 88.4
REMARK 3 NUMBER OF REFLECTIONS : 18614
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.226
REMARK 3 R VALUE (WORKING SET) : 0.222
REMARK 3 FREE R VALUE : 0.289
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200
REMARK 3 FREE R VALUE TEST SET COUNT : 1018
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.19
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.24
REMARK 3 REFLECTION IN BIN (WORKING SET) : 799
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 52.40
REMARK 3 BIN R VALUE (WORKING SET) : 0.2340
REMARK 3 BIN FREE R VALUE SET COUNT : 41
REMARK 3 BIN FREE R VALUE : 0.3290
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3498
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 118
REMARK 3 SOLVENT ATOMS : 186
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.64
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 2.78000
REMARK 3 B22 (A**2) : -3.33000
REMARK 3 B33 (A**2) : 0.32000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -1.38000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.544
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.303
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.218
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.412
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3715 ; 0.007 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5053 ; 1.047 ; 2.046
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 427 ; 5.394 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 180 ;33.112 ;23.889
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 637 ;18.076 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;19.000 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 527 ; 0.075 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2839 ; 0.005 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2147 ; 0.504 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3457 ; 0.934 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1568 ; 1.124 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1596 ; 1.883 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 3HOK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JUN-09.
REMARK 100 THE DEPOSITION ID IS D_1000053388.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 30-NOV-08
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.25
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : CHESS
REMARK 200 BEAMLINE : A1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9789
REMARK 200 MONOCHROMATOR : HORIZONTAL FOCUSING 5.05
REMARK 200 ASYMMETRIC CUT SI(111)
REMARK 200 OPTICS : BENT TRIANGULAR ASYMMETRIC CUT
REMARK 200 SI(111) MONOCHROMATER PROVIDES
REMARK 200 HORIZONTAL FOCUSING. RH-COATED
REMARK 200 SI MIRROR FOR VERTICAL FOCUSING.
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19633
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 89.9
REMARK 200 DATA REDUNDANCY : 3.300
REMARK 200 R MERGE (I) : 0.09800
REMARK 200 R SYM (I) : 0.09800
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.3100
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28
REMARK 200 COMPLETENESS FOR SHELL (%) : 68.8
REMARK 200 DATA REDUNDANCY IN SHELL : 2.60
REMARK 200 R MERGE FOR SHELL (I) : 0.35500
REMARK 200 R SYM FOR SHELL (I) : 0.35500
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.371
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: PDB ENTRY 1N3U
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 38.56
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 2.16 M AMMONIUM SULFATE, 1.15% 1,6
REMARK 280 -HEXANEDIOL, 0.1 M HEPES, PH 7.25, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 295K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.29600
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 1
REMARK 465 GLU A 2
REMARK 465 ARG A 3
REMARK 465 PRO A 4
REMARK 465 GLN A 5
REMARK 465 PRO A 6
REMARK 465 ASP A 7
REMARK 465 SER A 8
REMARK 465 MET A 9
REMARK 465 ASP A 224
REMARK 465 THR A 225
REMARK 465 LYS A 226
REMARK 465 ASP A 227
REMARK 465 GLN A 228
REMARK 465 SER A 229
REMARK 465 PRO A 230
REMARK 465 SER A 231
REMARK 465 ARG A 232
REMARK 465 ALA A 233
REMARK 465 MET B 1
REMARK 465 GLU B 2
REMARK 465 ARG B 3
REMARK 465 PRO B 4
REMARK 465 GLN B 5
REMARK 465 PRO B 6
REMARK 465 ASP B 7
REMARK 465 SER B 8
REMARK 465 ASP B 224
REMARK 465 THR B 225
REMARK 465 LYS B 226
REMARK 465 ASP B 227
REMARK 465 GLN B 228
REMARK 465 SER B 229
REMARK 465 PRO B 230
REMARK 465 SER B 231
REMARK 465 ARG B 232
REMARK 465 ALA B 233
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 THR A 21 13.27 -65.25
REMARK 500 ARG A 35 -42.56 169.41
REMARK 500 GLN A 38 -38.95 -130.56
REMARK 500 LYS A 39 -1.59 -55.74
REMARK 500 GLN A 41 42.68 -162.27
REMARK 500 GLU A 70 -24.70 96.56
REMARK 500 ARG A 113 -70.75 -41.69
REMARK 500 ARG A 136 -73.73 -68.37
REMARK 500 GLN A 145 -76.01 -96.50
REMARK 500 ALA A 151 -98.83 -51.81
REMARK 500 GLN A 152 -72.14 -30.47
REMARK 500 LEU A 155 -142.81 -129.62
REMARK 500 ASP A 156 -140.56 -88.73
REMARK 500 PRO A 158 167.40 -48.29
REMARK 500 SER A 159 53.88 -62.66
REMARK 500 GLN B 41 -79.39 -46.79
REMARK 500 VAL B 42 127.33 154.87
REMARK 500 GLU B 70 -29.85 93.73
REMARK 500 PHE B 74 -43.54 -131.16
REMARK 500 ALA B 75 -60.82 -24.55
REMARK 500 HIS B 84 124.30 -31.66
REMARK 500 ASP B 156 70.47 12.05
REMARK 500 PRO B 158 -171.53 -68.93
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 ASP A 156 LEU A 157 33.88
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 HEM A 300 FE
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS A 25 NE2
REMARK 620 2 HEM A 300 NA 97.5
REMARK 620 3 HEM A 300 NB 94.7 87.6
REMARK 620 4 HEM A 300 NC 79.3 176.3 90.9
REMARK 620 5 HEM A 300 ND 82.5 92.3 177.1 89.1
REMARK 620 N 1 2 3 4
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 HEM B 300 FE
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 HIS B 25 NE2
REMARK 620 2 HEM B 300 NA 80.8
REMARK 620 3 HEM B 300 NB 106.6 91.4
REMARK 620 4 HEM B 300 NC 96.9 177.6 89.9
REMARK 620 5 HEM B 300 ND 73.6 87.3 178.6 91.5
REMARK 620 N 1 2 3 4
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 300
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 300
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Q80 B 301
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3CZY RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 IN COMPLEX WITH 1-
REMARK 900 (ADAMANTAN-1-YL)-2-(1H-IMIDAZOL-1-YL)ETHANONE
REMARK 900 RELATED ID: 1N45 RELATED DB: PDB
REMARK 900 X-RAY CRYSTAL STRUCTURE OF HUMAN HEME OXYGENASE-1 (HO-1) IN COMPLEX
REMARK 900 WITH ITS SUBSTRATE HEME
DBREF 3HOK A 1 233 UNP P09601 HMOX1_HUMAN 1 233
DBREF 3HOK B 1 233 UNP P09601 HMOX1_HUMAN 1 233
SEQRES 1 A 233 MET GLU ARG PRO GLN PRO ASP SER MET PRO GLN ASP LEU
SEQRES 2 A 233 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS THR
SEQRES 3 A 233 GLN ALA GLU ASN ALA GLU PHE MET ARG ASN PHE GLN LYS
SEQRES 4 A 233 GLY GLN VAL THR ARG ASP GLY PHE LYS LEU VAL MET ALA
SEQRES 5 A 233 SER LEU TYR HIS ILE TYR VAL ALA LEU GLU GLU GLU ILE
SEQRES 6 A 233 GLU ARG ASN LYS GLU SER PRO VAL PHE ALA PRO VAL TYR
SEQRES 7 A 233 PHE PRO GLU GLU LEU HIS ARG LYS ALA ALA LEU GLU GLN
SEQRES 8 A 233 ASP LEU ALA PHE TRP TYR GLY PRO ARG TRP GLN GLU VAL
SEQRES 9 A 233 ILE PRO TYR THR PRO ALA MET GLN ARG TYR VAL LYS ARG
SEQRES 10 A 233 LEU HIS GLU VAL GLY ARG THR GLU PRO GLU LEU LEU VAL
SEQRES 11 A 233 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY
SEQRES 12 A 233 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ASP
SEQRES 13 A 233 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE
SEQRES 14 A 233 PRO ASN ILE ALA SER ALA THR LYS PHE LYS GLN LEU TYR
SEQRES 15 A 233 ARG SER ARG MET ASN SER LEU GLU MET THR PRO ALA VAL
SEQRES 16 A 233 ARG GLN ARG VAL ILE GLU GLU ALA LYS THR ALA PHE LEU
SEQRES 17 A 233 LEU ASN ILE GLN LEU PHE GLU GLU LEU GLN GLU LEU LEU
SEQRES 18 A 233 THR HIS ASP THR LYS ASP GLN SER PRO SER ARG ALA
SEQRES 1 B 233 MET GLU ARG PRO GLN PRO ASP SER MET PRO GLN ASP LEU
SEQRES 2 B 233 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS THR
SEQRES 3 B 233 GLN ALA GLU ASN ALA GLU PHE MET ARG ASN PHE GLN LYS
SEQRES 4 B 233 GLY GLN VAL THR ARG ASP GLY PHE LYS LEU VAL MET ALA
SEQRES 5 B 233 SER LEU TYR HIS ILE TYR VAL ALA LEU GLU GLU GLU ILE
SEQRES 6 B 233 GLU ARG ASN LYS GLU SER PRO VAL PHE ALA PRO VAL TYR
SEQRES 7 B 233 PHE PRO GLU GLU LEU HIS ARG LYS ALA ALA LEU GLU GLN
SEQRES 8 B 233 ASP LEU ALA PHE TRP TYR GLY PRO ARG TRP GLN GLU VAL
SEQRES 9 B 233 ILE PRO TYR THR PRO ALA MET GLN ARG TYR VAL LYS ARG
SEQRES 10 B 233 LEU HIS GLU VAL GLY ARG THR GLU PRO GLU LEU LEU VAL
SEQRES 11 B 233 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY
SEQRES 12 B 233 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA LEU ASP
SEQRES 13 B 233 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE
SEQRES 14 B 233 PRO ASN ILE ALA SER ALA THR LYS PHE LYS GLN LEU TYR
SEQRES 15 B 233 ARG SER ARG MET ASN SER LEU GLU MET THR PRO ALA VAL
SEQRES 16 B 233 ARG GLN ARG VAL ILE GLU GLU ALA LYS THR ALA PHE LEU
SEQRES 17 B 233 LEU ASN ILE GLN LEU PHE GLU GLU LEU GLN GLU LEU LEU
SEQRES 18 B 233 THR HIS ASP THR LYS ASP GLN SER PRO SER ARG ALA
HET HEM A 300 43
HET HEM B 300 43
HET Q80 B 301 32
HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE
HETNAM Q80 2-({[(2R,4S)-2-[2-(4-CHLOROPHENYL)ETHYL]-2-(1H-
HETNAM 2 Q80 IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-
HETNAM 3 Q80 YL]METHYL}SULFANYL)-5-(TRIFLUOROMETHYL)PYRIDINE
HETSYN HEM HEME
FORMUL 3 HEM 2(C34 H32 FE N4 O4)
FORMUL 5 Q80 C22 H21 CL F3 N3 O2 S
FORMUL 6 HOH *186(H2 O)
HELIX 1 1 ASP A 12 THR A 21 1 10
HELIX 2 2 THR A 21 ALA A 31 1 11
HELIX 3 3 GLU A 32 PHE A 37 1 6
HELIX 4 4 THR A 43 LYS A 69 1 27
HELIX 5 5 PHE A 74 TYR A 78 5 5
HELIX 6 6 PHE A 79 HIS A 84 1 6
HELIX 7 7 ARG A 85 GLY A 98 1 14
HELIX 8 8 ARG A 100 ILE A 105 1 6
HELIX 9 9 THR A 108 GLU A 125 1 18
HELIX 10 10 LEU A 128 GLY A 144 1 17
HELIX 11 11 GLN A 145 ALA A 154 1 10
HELIX 12 12 LEU A 164 THR A 168 5 5
HELIX 13 13 SER A 174 ASN A 187 1 14
HELIX 14 14 THR A 192 LEU A 221 1 30
HELIX 15 15 ASP B 12 THR B 21 1 10
HELIX 16 16 THR B 21 LYS B 39 1 19
HELIX 17 17 THR B 43 LYS B 69 1 27
HELIX 18 18 PHE B 74 TYR B 78 5 5
HELIX 19 19 PHE B 79 HIS B 84 1 6
HELIX 20 20 ARG B 85 TYR B 97 1 13
HELIX 21 21 ARG B 100 ILE B 105 1 6
HELIX 22 22 THR B 108 GLU B 125 1 18
HELIX 23 23 LEU B 128 LEU B 155 1 28
HELIX 24 24 LEU B 164 THR B 168 5 5
HELIX 25 25 SER B 174 ASN B 187 1 14
HELIX 26 26 THR B 192 LEU B 221 1 30
LINK NE2 HIS A 25 FE HEM A 300 1555 1555 2.28
LINK NE2 HIS B 25 FE HEM B 300 1555 1555 2.24
SITE 1 AC1 13 HIS A 25 ALA A 28 GLU A 29 TYR A 134
SITE 2 AC1 13 THR A 135 GLY A 139 SER A 142 ARG A 183
SITE 3 AC1 13 PHE A 207 ASN A 210 PHE A 214 HOH A 323
SITE 4 AC1 13 HOH A 332
SITE 1 AC2 14 LYS B 18 HIS B 25 ALA B 28 GLU B 29
SITE 2 AC2 14 GLU B 32 TYR B 134 THR B 135 LEU B 138
SITE 3 AC2 14 GLY B 139 SER B 142 ARG B 183 PHE B 207
SITE 4 AC2 14 ASN B 210 Q80 B 301
SITE 1 AC3 11 ALA B 31 ARG B 35 VAL B 50 GLY B 139
SITE 2 AC3 11 ASP B 140 GLY B 143 LEU B 147 PHE B 167
SITE 3 AC3 11 PHE B 214 GLU B 215 HEM B 300
CRYST1 55.072 54.592 71.884 90.00 94.64 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018158 0.000000 0.001474 0.00000
SCALE2 0.000000 0.018318 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013957 0.00000